-+ 0.00%
-+ 0.00%
-+ 0.00%

IGC Pharma Reaches 65% Enrollment in Phase 2 CALMA Trial for Alzheimer’s Agitation

Reuters·12/09/2025 14:00:41

Please log in to view news